© 2003 by Oxford University Press
Journal of the National Cancer Institute Monographs, No. 31, 20-28,
2003
© 2003 Oxford University Press
ARTICLE |
Chapter 3: Cofactors in Human Papillomavirus CarcinogenesisRole of Parity, Oral Contraceptives, and Tobacco Smoking
Affiliations of authors: X. Castellsagué, Institut Català dOncologia, Servei dEpidemiologia i Registre del Càncer, LHospitalet de Llobregat, Barcelona, Spain; N. Muñoz, International Agency for Research on Cancer, Lyon, France.
Correspondence to: Xavier Castellsagué, M.D., Ph.D., M.P.H., Institut Català dOncologia, Servei dEpidemiologia i Registre del Càncer, Gran via s/n, km 2.7, 08907 LHospitalet de Llobregat, Barcelona, Spain (e-mail: xcastellsague{at}ico.scs.es).
It is now well established that infection with oncogenic human papillomavirus (HPV) types is the necessary cause of cervical cancer (CC) and its immediate precursor cervical intraepithelial neoplasia 3. However, HPV infection alone may not be sufficient to cause CC, and other exogenous and endogenous factors may exist that, in conjunction with HPV, influence the risk of progression from cervical HPV infection to CC. In this chapter, we review the evidence for the role of parity, oral contraceptive (OC) use, and tobacco smoking in CC. We also discuss limitations and methodologic problems encountered in assessing available data and outline recommendations for future research. Based on key studies on high-grade squamous intraepithelial lesions (HSILs) and CC conducted among HPV-positive women, it can be concluded that high parity, smoking, and less consistently long-term OC use are cofactors that may modulate the risk of progression from HPV infection to HSIL/CC. From a public health point of view, parity seems to be the behavioral cofactor explaining the highest proportion of CC cases among HPV-infected women. Smoking and long-term OC use may have a similar impact in populations that are heavily exposed to HPV and to these cofactors. Large prospective and retrospective cohort studies of HSIL and CC among middle-aged women in which several markers of HPV exposure are used and HPV persistence is documented would be valuable to study the role of these and other cofactors in HPV carcinogenesis. If confirmed, our conclusions may imply that multiparous women, women who are smokers, and women on long-term OC use may need closer surveillance for cytologic abnormalities and HPV infections than women in the general population.
This article has been cited by other articles:
![]() |
S. K. Hussain, M. M. Madeleine, L. G. Johnson, Q. Du, M. Malkki, H.-W. Wilkerson, F. M. Farin, J. J. Carter, D. A. Galloway, J. R. Daling, et al. Cervical and Vulvar Cancer Risk in Relation to the Joint Effects of Cigarette Smoking and Genetic Variation in Interleukin 2 Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1790 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Castle, C. Meyers, S. Alam, and M. J. Conway How Does Tobacco Smoke Contribute to Cervical Carcinogenesis? J. Virol., June 15, 2008; 82(12): 6084 - 6086. [Full Text] [PDF] |
||||
![]() |
M. L. Tornesello, M. L. Duraturo, P. Giorgi-Rossi, M. Sansone, R. Piccoli, L. Buonaguro, and F. M. Buonaguro Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women J. Gen. Virol., June 1, 2008; 89(6): 1380 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Syrjanen, P Naud, S Derchain, C Roteli-Martins, A Longatto-Filho, S Tatti, M Branca, M Erzen, L S Hammes, J Matos, et al. Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort Int J STD AIDS, April 1, 2008; 19(4): 251 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Chaturvedi, E. A. Engels, E. S. Gilbert, B. E. Chen, H. Storm, C. F. Lynch, P. Hall, F. Langmark, E. Pukkala, M. Kaijser, et al. Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk J Natl Cancer Inst, November 7, 2007; 99(21): 1634 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Wood, Z. Chen, J. M. Cline, B. E. Miller, and R. D. Burk Characterization and Experimental Transmission of an Oncogenic Papillomavirus in Female Macaques J. Virol., June 15, 2007; 81(12): 6339 - 6345. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Goodman, Y. B. Shvetsov, K. McDuffie, L. R. Wilkens, X. Zhu, A. A. Franke, C. C. Bertram, B. Kessel, M. Bernice, C. Sunoo, et al. Hawaii Cohort Study of Serum Micronutrient Concentrations and Clearance of Incident Oncogenic Human Papillomavirus Infection of the Cervix Cancer Res., June 15, 2007; 67(12): 5987 - 5996. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fakhry, G. D'souza, E. Sugar, K. Weber, E. Goshu, H. Minkoff, R. Wright, E. Seaberg, and M. Gillison Relationship between Prevalent Oral and Cervical Human Papillomavirus Infections in Human Immunodeficiency Virus-Positive and -Negative Women J. Clin. Microbiol., December 1, 2006; 44(12): 4479 - 4485. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vaccarella, R. Herrero, M. Dai, P. J.F. Snijders, C. J.L.M. Meijer, J. O. Thomas, P. T. Hoang Anh, C. Ferreccio, E. Matos, H. Posso, et al. Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2148 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Weaver Epidemiology and Natural History of Genital Human Papillomavirus Infection J Am Osteopath Assoc, March 1, 2006; 106(suppl_1): S2 - S8. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Shields, L. A. Brinton, R. D. Burk, S. S. Wang, S. J. Weinstein, R. G. Ziegler, Y. Y. Studentsov, M. McAdams, and M. Schiffman A Case-Control Study of Risk Factors for Invasive Cervical Cancer among U.S. Women Exposed to Oncogenic Types of Human Papillomavirus Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1574 - 1582. [Abstract] [Full Text] [PDF] |
||||







